Mubadala Launches Mubadala Bio to Advance UAE’s Life Sciences and Drug Security  

Mubadala Investment Company has officially launched Mubadala Bio, a new life sciences company designed to boost the UAE’s healthcare capabilities and establish Abu Dhabi as a global hub for medical innovation and biopharma manufacturing. The announcement underscores Mubadala’s long-term strategy to advance national drug security, support economic diversification, and accelerate better health outcomes both locally and globally. 

Positioned as a National Champion, Mubadala Bio reflects the UAE’s deepening commitment to building a resilient healthcare infrastructure and knowledge-based economy. The company’s launch represents a strategic pivot toward greater healthcare resilience, expanded access to high-quality therapeutics, and accelerated production and distribution capacity from the UAE to the world. 

A Global Footprint Rooted in Local Strength 

With a portfolio of 10 facilities across Asia, Africa, and Europe, including six based in the UAE, Mubadala Bio brings integrated manufacturing capabilities to more than 100 countries. These facilities collectively produce over 2.5 billion tablets and capsules, 120 million IVs and injectables annually, and cover 110,000 square meters of production space. 

The company’s product pipeline addresses some of the world’s most pressing therapeutic needs and supports the full continuum of care, from prevention and diagnosis to treatment, ongoing support, and complementary medicine. 

By leveraging long-term collaborations with global industry leaders and academic institutions, Mubadala Bio is positioned to accelerate innovation, cultivate world-class talent, and drive local biopharma development.

Also Read: MedTech World Partners with MedTech Innovator for Exclusive Startup-Investor Event in Bay Area, California

Leadership Vision: Health Innovation Meets Economic Ambition 

Commenting on the launch, Dr. Bakheet Al Katheeri, CEO of Mubadala’s UAE Investments Platform, said in a statement: 

“By launching Mubadala Bio, we are taking a transformative step towards strengthening national drug security and fostering innovation in life sciences. This positions Mubadala at the forefront of the industry, enabling us to drive long-term economic growth, build a resilient life sciences ecosystem, and elevate Abu Dhabi’s role in delivering impactful health solutions on a global scale.” 

Echoing the sentiment, Ismail Ali Abdulla, Executive Director of UAE Clusters at Mubadala’s UAE Investments Platform, added: 

“With the launch of Mubadala Bio, we are proud to take a significant step forward in supporting the UAE’s ambition to be a global leader in the life sciences industry. By focusing on local manufacturing and enhancing our distribution and logistics capabilities, we are building a more resilient and self-sustaining life sciences sector, one that responds to today’s needs while preparing for tomorrow’s challenges.” 

Also Read: Will Your Name Be Among MedTech’s Top Innovators in 2025? MedTech Malta Award Nominations Are Now Open

Looking Ahead: A Platform for the UAE’s 2071 Vision 

Mubadala Bio marked its first physical presence at Make it in the Emirates 2025, where it showcased the UAE’s progress in building a competitive and innovative life sciences sector. The company’s integrated focus on biopharma and pharma logistics aims to align with the UAE Centennial 2071 vision, reinforcing the nation’s positioning as a center for innovation, sustainability, and global health collaboration. 

As the UAE continues to invest in strategic sectors with long-term impact, Mubadala Bio stands out as a pivotal initiative for advancing public health, scientific progress, and economic resilience at home and abroad. 

Up next: MedTech World Europe 2026 | Malta

MedTech World returns to Malta for MedTech World Europe 2026, its biggest edition yet. Taking place from 11-13 November 2026, MedTech Malta Week expands the traditional conference into a five-day experience across Malta and Gozo, bringing together investors, founders, healthcare leaders, innovators, and industry experts from across the global MedTech ecosystem.

The week opens with the MedTech World Investors Retreat in Gozo from 9–11 November, offering accredited investors and senior industry leaders an exclusive setting for strategic conversations, networking, workshops, and curated experiences. The programme then moves to Malta for a cultural immersion day in Valletta and Mdina on 11 November, before the main MedTech World Europe conference takes place from 11 to 13 November at the Mediterranean Conference Centre in Valletta.

Throughout the conference, attendees can expect keynote sessions, panel discussions, workshops, company showcases, investor meetings, an exhibition floor, and the MedTech World Startup Pitch Competition, followed by the MedTech World Gala Awards, honoring achievements across the global MedTech ecosystem.

Interested in being part of the biggest MedTech World Europe yet? Book your ticket now.